Skip to main content

Ikarian Capital, LLC

Position in COGT — Cogent Biosciences, Inc.

CIK 1778253 DALLAS, TX

Position in COGT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$14,322,250
+$14,160,270 QoQ
Shares Held
370,084
+3180.9% QoQ
Ownership
0.213%
of shares outstanding
% of Portfolio
2.32%
of 13F equity value
Holder Rank
#77
of 321 holders
Holding Since
Dec 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in COGT Over Time

Shares Held

Position Value (USD)

Derivatives in COGT

reported options exposure · as of Jun 30, 2025
CallValue
$1,885,468
CallShares
262,600
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. COGT ranks #10 (2.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in COGT

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,322,250 370,084
2025-09-30 $161,980 11,280
2025-06-30 $7,435,091 1,035,528
2025-06-30 $1,885,468 262,600
2023-09-30 $611,968 62,766
2023-06-30 $743,149 62,766
2023-03-31 $677,245 62,766
2022-12-31 $725,574 62,766
2022-09-30 $2,428,468 162,766
2022-06-30 $2,255,000 250,000
2021-09-30 $258,414 30,727
2021-06-30 $338,689 41,762
2021-03-31 $366,670 41,762
2020-12-31 $468,987 41,762